Tapewire

NYSE · USD

CVS

CVS HEALTH Corp

Export transactions ↓
Tapewire entity
2884
SEC CIK
0000064803
Parsed reports
1,748

Last 12 months

Inside the activity.

0 purchase rows · 8 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202608
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
April 01, 2020 Filed Apr 3, 2020 21:25 UTC
Boratto Eva CEVP & CFO
Tax withholdingCommon Stock 887 $58.34 $51,747.58
Disclosure

SEC source: 0001127602-20-013230 · form4.xml · nonDerivative · entry 1

Boratto Eva C · CIK 0001580827 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,520.5255

F1 · shares: Surrrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award.

Read SEC document
April 01, 2020 Filed Apr 3, 2020 21:26 UTC
Moriarty Thomas MEVP & General Counsel
GrantStock Option · Derivative 197,116 $58.61 Strike: $58.61 $11,552,968.76
Disclosure

SEC source: 0001127602-20-013231 · form4.xml · derivative · entry 4

Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 197,116

Underlying: Common Stock · 197,116 shares

Expires 2030-04-01

F2 · derivative.exercise_price: The number of shares subject to the option were calculated using a 30-day average price.

F3 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2021.

Read SEC document
April 01, 2020 Filed Apr 3, 2020 21:26 UTC
Moriarty Thomas MEVP & General Counsel
Tax withholdingCommon Stock 1,806 $58.34 $105,362.04
Disclosure

SEC source: 0001127602-20-013231 · form4.xml · nonDerivative · entry 1

Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,374.0221

F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award.

Read SEC document
April 01, 2020 Filed Apr 3, 2020 21:28 UTC
Brennan Troyen AEVP and Chief Medical Officer
GrantStock Option · Derivative 112,637 $58.61 Strike: $58.61 $6,601,654.57
Disclosure

SEC source: 0001127602-20-013232 · form4.xml · derivative · entry 3

Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 112,637

Underlying: Common Stock · 112,637 shares

Expires 2030-04-01

F2 · derivative.exercise_price: The number of shares subject to the option were calculated using a 30-day average price.

F3 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2021.

Read SEC document
April 01, 2020 Filed Apr 3, 2020 21:28 UTC
Brennan Troyen AEVP and Chief Medical Officer
Tax withholdingCommon Stock 1,552 $58.34 $90,543.68
Disclosure

SEC source: 0001127602-20-013232 · form4.xml · nonDerivative · entry 1

Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 102,279.059

F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award.

Read SEC document
April 01, 2020 Filed Apr 3, 2020 21:29 UTC
Bisaccia LisaEVP and Chief HR Officer
GrantStock Option · Derivative 98,558 $58.61 Strike: $58.61 $5,776,484.38
Disclosure

SEC source: 0001127602-20-013233 · form4.xml · derivative · entry 5

Bisaccia Lisa · CIK 0001479663 · EVP and Chief HR Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 98,558

Underlying: Common Stock · 98,558 shares

Expires 2030-04-01

F2 · derivative.exercise_price: The number of shares subject to the option were calculated using a 30-day average price.

F3 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2021.

Read SEC document
April 01, 2020 Filed Apr 3, 2020 21:29 UTC
Bisaccia LisaEVP and Chief HR Officer
Tax withholdingCommon Stock 1,109 $58.34 $64,699.06
Disclosure

SEC source: 0001127602-20-013233 · form4.xml · nonDerivative · entry 1

Bisaccia Lisa · CIK 0001479663 · EVP and Chief HR Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,663

F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award.

Read SEC document
April 01, 2020 Filed Apr 3, 2020 21:32 UTC
Lotvin AlanEVP, Transformation
GrantStock Option · Derivative 140,797 $58.61 Strike: $58.61 $8,252,112.17
Disclosure

SEC source: 0001127602-20-013234 · form4.xml · derivative · entry 5

Lotvin Alan · CIK 0001472795 · EVP, Transformation

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 140,797

Underlying: Common Stock · 140,797 shares

Expires 2030-04-01

F2 · derivative.exercise_price: The number of shares subject to the option were calculated using a 30-day average price.

F3 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2021.

Read SEC document
April 01, 2020 Filed Apr 3, 2020 21:32 UTC
Lotvin AlanEVP, Transformation
Tax withholdingCommon Stock 1,481 $58.34 $86,401.54
Disclosure

SEC source: 0001127602-20-013234 · form4.xml · nonDerivative · entry 1

Lotvin Alan · CIK 0001472795 · EVP, Transformation

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,161.3273

F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award.

Read SEC document
April 01, 2020 Filed Apr 3, 2020 21:33 UTC
Flum Joshua MatthewEVP, ENT STRATEGY & DIGITAL
GrantStock Option · Derivative 63,358 $58.61 Strike: $58.61 $3,713,412.38
Disclosure

SEC source: 0001127602-20-013235 · form4.xml · derivative · entry 3

Flum Joshua Matthew · CIK 0001412223 · EVP, ENT STRATEGY & DIGITAL

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,358

Underlying: Common Stock · 63,358 shares

Expires 2030-04-01

F2 · derivative.exercise_price: The number of shares subject to the option were calculated using a 30-day average price.

F3 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2021.

Read SEC document
April 01, 2020 Filed Apr 3, 2020 21:33 UTC
Flum Joshua MatthewEVP, ENT STRATEGY & DIGITAL
Tax withholdingCommon Stock 973 $58.34 $56,764.82
Disclosure

SEC source: 0001127602-20-013235 · form4.xml · nonDerivative · entry 1

Flum Joshua Matthew · CIK 0001412223 · EVP, ENT STRATEGY & DIGITAL

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000.958

F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award.

Read SEC document
April 01, 2020 Filed Apr 3, 2020 21:35 UTC
Lynch Karen SEVP & Pres, Aetna Bus Unit
GrantStock Option · Derivative 211,196 $58.61 Strike: $58.61 $12,378,197.56
Disclosure

SEC source: 0001127602-20-013236 · form4.xml · derivative · entry 3

Lynch Karen S · CIK 0001333760 · EVP & Pres, Aetna Bus Unit

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 211,196

Underlying: Common Stock · 211,196 shares

Expires 2030-04-01

F1 · derivative.exercise_price: The number of shares subject to the option were calculated using a 30-day average price.

F2 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2021.

Read SEC document
April 01, 2020 Filed Apr 3, 2020 21:36 UTC
Mayhew Jonathan E.EVP, Chief Transformation Off
GrantStock Option · Derivative 28,159 $58.61 Strike: $58.61 $1,650,398.99
Disclosure

SEC source: 0001127602-20-013237 · form4.xml · derivative · entry 4

Mayhew Jonathan E. · CIK 0001806604 · EVP, Chief Transformation Off

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,159

Underlying: Common Stock · 28,159 shares

Expires 2030-04-01

F2 · derivative.exercise_price: The number of shares subject to the option were calculated using a 30-day average price.

F3 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2021.

Read SEC document
April 01, 2020 Filed Apr 3, 2020 21:36 UTC
Mayhew Jonathan E.EVP, Chief Transformation Off
Tax withholdingCommon Stock 763 $58.34 $44,513.42
Disclosure

SEC source: 0001127602-20-013237 · form4.xml · nonDerivative · entry 1

Mayhew Jonathan E. · CIK 0001806604 · EVP, Chief Transformation Off

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,288

F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award.

Read SEC document
April 01, 2020 Filed Apr 3, 2020 21:37 UTC
Clark James DavidSVP, Cont & Chief Acct Officer
GrantStock Option · Derivative 17,157 $58.34 Strike: $58.34 $1,000,939.38
Disclosure

SEC source: 0001127602-20-013238 · form4.xml · derivative · entry 3

Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,157

Underlying: Common Stock · 17,157 shares

Expires 2030-04-01

F3 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2021.

Read SEC document
April 01, 2020 Filed Apr 3, 2020 21:37 UTC
Clark James DavidSVP, Cont & Chief Acct Officer
GrantCommon Stock (restricted) 7,713 $58.34 $449,976.42
Disclosure

SEC source: 0001127602-20-013238 · form4.xml · nonDerivative · entry 2

Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,204

F2 · shares: Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in four equal installments, commencing 4/1/2021.

Read SEC document
April 01, 2020 Filed Apr 3, 2020 21:37 UTC
Clark James DavidSVP, Cont & Chief Acct Officer
Tax withholdingCommon Stock 681 $58.34 $39,729.54
Disclosure

SEC source: 0001127602-20-013238 · form4.xml · nonDerivative · entry 1

Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,321.2554

F1 · shares: Surrrender of shares in payment of withholding taxes due upon the vesting of restricted stock awards.

Read SEC document
April 01, 2020 Filed Apr 7, 2020 21:32 UTC Amendment
MERLO LARRY JDirector · President and CEO
GrantStock Option · Derivative 478,711 $0.00 Strike: $58.34 $0.00
Disclosure

SEC source: 0001127602-20-013399 · form4a.xml · derivative · entry 1

MERLO LARRY J · CIK 0001194413 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 478,711

Underlying: Common Stock · 478,711 shares

Expires 2030-04-01

F1 · derivative.exercise_price: This Form 4/A is being filed in order to correct the exercise price (Table II, column 2) for the stock option granted on 4/1/2020, which was reported incorrectly on the original Form 4 due to a clerical error.

Read SEC document
April 01, 2020 Filed Apr 7, 2020 21:33 UTC Amendment
Roberts Jonathan CEVP & Chief Operating Officer
GrantStock Option · Derivative 239,355 $0.00 Strike: $58.34 $0.00
Disclosure

SEC source: 0001127602-20-013402 · form4a.xml · derivative · entry 1

Roberts Jonathan C · CIK 0001410515 · EVP & Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 239,355

Underlying: Common Stock · 239,355 shares

Expires 2030-04-01

F1 · derivative.exercise_price: This Form 4/A is being filed in order to correct the exercise price (Table II, column 2) for the stock option granted on 4/1/2020, which was reported incorrectly on the original Form 4 due to a clerical error.

Read SEC document
April 01, 2020 Filed Apr 7, 2020 21:34 UTC Amendment
Boratto Eva CEVP & CFO
GrantStock Option · Derivative 168,956 $0.00 Strike: $58.34 $0.00
Disclosure

SEC source: 0001127602-20-013404 · form4a.xml · derivative · entry 1

Boratto Eva C · CIK 0001580827 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 168,956

Underlying: Common Stock · 168,956 shares

Expires 2030-04-01

F1 · derivative.exercise_price: This Form 4/A is being filed in order to correct the exercise price (Table II, column 2) for the stock option granted on 4/1/2020, which was reported incorrectly on the original Form 4 due to a clerical error.

Read SEC document
April 01, 2020 Filed Apr 7, 2020 21:36 UTC Amendment
Moriarty Thomas MEVP & General Counsel
GrantStock Option · Derivative 197,116 $0.00 Strike: $58.34 $0.00
Disclosure

SEC source: 0001127602-20-013406 · form4a.xml · derivative · entry 1

Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 197,116

Underlying: Common Stock · 197,116 shares

Expires 2030-04-01

F1 · derivative.exercise_price: This Form 4/A is being filed in order to correct the exercise price (Table II, column 2) for the stock option granted on 4/1/2020, which was reported incorrectly on the original Form 4 due to a clerical error.

Read SEC document
April 01, 2020 Filed Apr 7, 2020 21:37 UTC Amendment
Brennan Troyen AEVP and Chief Medical Officer
GrantStock Option · Derivative 112,637 $0.00 Strike: $58.34 $0.00
Disclosure

SEC source: 0001127602-20-013407 · form4a.xml · derivative · entry 1

Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 112,637

Underlying: Common Stock · 112,637 shares

Expires 2030-04-01

F1 · derivative.exercise_price: This Form 4/A is being filed in order to correct the exercise price (Table II, column 2) for the stock option granted on 4/1/2020, which was reported incorrectly on the original Form 4 due to a clerical error.

Read SEC document
April 01, 2020 Filed Apr 7, 2020 21:38 UTC Amendment
Bisaccia LisaEVP and Chief HR Officer
GrantStock Option · Derivative 98,558 $0.00 Strike: $58.34 $0.00
Disclosure

SEC source: 0001127602-20-013409 · form4a.xml · derivative · entry 1

Bisaccia Lisa · CIK 0001479663 · EVP and Chief HR Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 98,558

Underlying: Common Stock · 98,558 shares

Expires 2030-04-01

F1 · derivative.exercise_price: This Form 4/A is being filed in order to correct the exercise price (Table II, column 2) for the stock option granted on 4/1/2020, which was reported incorrectly on the original Form 4 due to a clerical error.

Read SEC document
April 01, 2020 Filed Apr 7, 2020 21:39 UTC Amendment
Lotvin AlanEVP, Transformation
GrantStock Option · Derivative 140,797 $0.00 Strike: $58.34 $0.00
Disclosure

SEC source: 0001127602-20-013410 · form4a.xml · derivative · entry 1

Lotvin Alan · CIK 0001472795 · EVP, Transformation

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 140,797

Underlying: Common Stock · 140,797 shares

Expires 2030-04-01

F1 · derivative.exercise_price: This Form 4/A is being filed in order to correct the exercise price (Table II, column 2) for the stock option granted on 4/1/2020, which was reported incorrectly on the original Form 4 due to a clerical error.

Read SEC document
April 01, 2020 Filed Apr 7, 2020 21:40 UTC Amendment
Flum Joshua MatthewEVP, ENT STRATEGY & DIGITAL
GrantStock Option · Derivative 63,358 $0.00 Strike: $58.34 $0.00
Disclosure

SEC source: 0001127602-20-013412 · form4a.xml · derivative · entry 1

Flum Joshua Matthew · CIK 0001412223 · EVP, ENT STRATEGY & DIGITAL

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,358

Underlying: Common Stock · 63,358 shares

Expires 2030-04-01

F1 · derivative.exercise_price: This Form 4/A is being filed in order to correct the exercise price (Table II, column 2) for the stock option granted on 4/1/2020, which was reported incorrectly on the original Form 4 due to a clerical error.

Read SEC document
April 01, 2020 Filed Apr 7, 2020 21:41 UTC Amendment
Lynch Karen SEVP & Pres, Aetna Bus Unit
GrantStock Option · Derivative 211,196 $0.00 Strike: $58.34 $0.00
Disclosure

SEC source: 0001127602-20-013413 · form4a.xml · derivative · entry 1

Lynch Karen S · CIK 0001333760 · EVP & Pres, Aetna Bus Unit

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 211,196

Underlying: Common Stock · 211,196 shares

Expires 2030-04-01

F1 · derivative.exercise_price: This Form 4/A is being filed in order to correct the exercise price (Table II, column 2) for the stock option granted on 4/1/2020, which was reported incorrectly on the original Form 4 due to a clerical error.

Read SEC document
April 01, 2020 Filed Apr 7, 2020 21:42 UTC Amendment
Mayhew Jonathan E.EVP, Chief Transformation Off
GrantStock Option · Derivative 28,159 $0.00 Strike: $58.34 $0.00
Disclosure

SEC source: 0001127602-20-013415 · form4a.xml · derivative · entry 1

Mayhew Jonathan E. · CIK 0001806604 · EVP, Chief Transformation Off

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,159

Underlying: Common Stock · 28,159 shares

Expires 2030-04-01

F1 · derivative.exercise_price: This Form 4/A is being filed in order to correct the exercise price (Table II, column 2) for the stock option granted on 4/1/2020, which was reported incorrectly on the original Form 4 due to a clerical error.

Read SEC document
March 30, 2020 Filed Apr 1, 2020 21:14 UTC
Clark James DavidSVP, Cont & Chief Acct Officer
Exercise / conversionStock Option · Derivative 3,030 $0.00 Strike: $54.53 $0.00
Disclosure

SEC source: 0001127602-20-012450 · form4.xml · derivative · entry 4

Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,030 shares

Expires 2020-04-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Remaining options became exercisable in four equal annual installments beginning on 4/1/2014.

Read SEC document
March 30, 2020 Filed Apr 1, 2020 21:14 UTC
Clark James DavidSVP, Cont & Chief Acct Officer
SaleCommon Stock 3,030 $60.00 $181,800.00
Disclosure

SEC source: 0001127602-20-012450 · form4.xml · nonDerivative · entry 2

Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,760.2554

F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan.

Read SEC document
March 30, 2020 Filed Apr 1, 2020 21:14 UTC
Clark James DavidSVP, Cont & Chief Acct Officer
Exercise / conversionCommon Stock 3,030 $54.53 $165,225.90
Disclosure

SEC source: 0001127602-20-012450 · form4.xml · nonDerivative · entry 1

Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,790.2554

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 28, 2020 Filed Mar 3, 2020 22:32 UTC
Bisaccia LisaEVP and Chief HR Officer
Tax withholdingCommon Stock 6,202 $59.18 $367,034.36
Disclosure

SEC source: 0001127602-20-009151 · form4.xml · nonDerivative · entry 2

Bisaccia Lisa · CIK 0001479663 · EVP and Chief HR Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,327

F2 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of stock awards under the Issuer's 2017 Incentive Compensation Plan and its Long-Term Incentive Plan.

Read SEC document
February 28, 2020 Filed Mar 3, 2020 22:32 UTC
Bisaccia LisaEVP and Chief HR Officer
GrantCommon Stock 18,587 $59.18 $1,099,978.66
Disclosure

SEC source: 0001127602-20-009151 · form4.xml · nonDerivative · entry 1

Bisaccia Lisa · CIK 0001479663 · EVP and Chief HR Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,529

F1 · shares: Consists of stock awarded at market price pursuant to Issuer's 2017 Incentive Compensation Plan and its Long-Term Incentive Plan.

Read SEC document
February 28, 2020 Filed Mar 3, 2020 22:35 UTC
Boratto Eva CEVP & CFO
Tax withholdingCommon Stock 13,193 $59.18 $780,761.74
Disclosure

SEC source: 0001127602-20-009155 · form4.xml · nonDerivative · entry 3

Boratto Eva C · CIK 0001580827 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 68,451.5255

F3 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of stock awards under the Issuer's 2017 Incentive Compensation Plan and its Long-Term Incentive Plan.

Read SEC document
February 28, 2020 Filed Mar 3, 2020 22:35 UTC
Boratto Eva CEVP & CFO
GrantCommon Stock 33,795 $59.18 $1,999,988.10
Disclosure

SEC source: 0001127602-20-009155 · form4.xml · nonDerivative · entry 2

Boratto Eva C · CIK 0001580827 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 81,644.5255

F2 · shares: Consists of stock awarded at market price pursuant to Issuer's 2017 Incentive Compensation Plan and its Long-Term Incentive Plan.

Read SEC document
February 28, 2020 Filed Mar 3, 2020 22:35 UTC
Boratto Eva CEVP & CFO
Tax withholdingCommon Stock 137 $59.18 $8,107.66
Disclosure

SEC source: 0001127602-20-009155 · form4.xml · nonDerivative · entry 1

Boratto Eva C · CIK 0001580827 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,849.5255

F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award.

Read SEC document
February 28, 2020 Filed Mar 3, 2020 22:37 UTC
Brennan Troyen AEVP and Chief Medical Officer
Tax withholdingCommon Stock 9,255 $59.18 $547,710.90
Disclosure

SEC source: 0001127602-20-009159 · form4.xml · nonDerivative · entry 2

Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,408.059

F2 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of stock awards under the Issuer's 2017 Incentive Compensation Plan and its Long-Term Incentive Plan.

Read SEC document
February 28, 2020 Filed Mar 3, 2020 22:37 UTC
Brennan Troyen AEVP and Chief Medical Officer
GrantCommon Stock 25,346 $59.18 $1,499,976.28
Disclosure

SEC source: 0001127602-20-009159 · form4.xml · nonDerivative · entry 1

Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 109,663.059

F1 · shares: Consists of stock awarded at market price pursuant to Issuer's 2017 Incentive Compensation Plan and its Long-Term Incentive Plan.

Read SEC document
February 28, 2020 Filed Mar 3, 2020 22:38 UTC
Clark James DavidSVP, Cont & Chief Acct Officer
GrantCommon Stock (restricted) 1,912 $59.18 $113,152.16
Disclosure

SEC source: 0001127602-20-009161 · form4.xml · nonDerivative · entry 2

Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,733

F2 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2017 Incentive Compensation Plan its Performance-Based Restricted Stock Unit Plan. Restrictions lapse in three equal installments, commencing February 28, 2021.

Read SEC document
February 28, 2020 Filed Mar 3, 2020 22:38 UTC
Clark James DavidSVP, Cont & Chief Acct Officer
Tax withholdingCommon Stock 347 $59.18 $20,535.46
Disclosure

SEC source: 0001127602-20-009161 · form4.xml · nonDerivative · entry 1

Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,760.2554

F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award.

Read SEC document
February 28, 2020 Filed Mar 3, 2020 22:39 UTC
Flum Joshua MatthewEVP, ENT STRATEGY & DIGITAL
GrantCommon Stock (restricted) 1 $59.18 $59.18
Disclosure

SEC source: 0001127602-20-009163 · form4.xml · nonDerivative · entry 4

Flum Joshua Matthew · CIK 0001412223 · EVP, ENT STRATEGY & DIGITAL

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,691

F3 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2017 Incentive Compensation Plan its Performance-Based Restricted Stock Unit Plan. Restrictions lapse in three equal installments, commencing February 28, 2021.

Read SEC document
February 28, 2020 Filed Mar 3, 2020 22:39 UTC
Flum Joshua MatthewEVP, ENT STRATEGY & DIGITAL
Tax withholdingCommon Stock 1,026 $59.18 $60,718.68
Disclosure

SEC source: 0001127602-20-009163 · form4.xml · nonDerivative · entry 3

Flum Joshua Matthew · CIK 0001412223 · EVP, ENT STRATEGY & DIGITAL

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,827.958

F2 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of stock awards under the Issuer's 2017 Incentive Compensation Plan and its Long-Term Incentive Plan.

Read SEC document
February 28, 2020 Filed Mar 3, 2020 22:39 UTC
Flum Joshua MatthewEVP, ENT STRATEGY & DIGITAL
GrantCommon Stock 3,379 $59.18 $199,969.22
Disclosure

SEC source: 0001127602-20-009163 · form4.xml · nonDerivative · entry 2

Flum Joshua Matthew · CIK 0001412223 · EVP, ENT STRATEGY & DIGITAL

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,853.958

Read SEC document
February 28, 2020 Filed Mar 3, 2020 22:39 UTC
Flum Joshua MatthewEVP, ENT STRATEGY & DIGITAL
Tax withholdingCommon Stock 498 $59.18 $29,471.64
Disclosure

SEC source: 0001127602-20-009163 · form4.xml · nonDerivative · entry 1

Flum Joshua Matthew · CIK 0001412223 · EVP, ENT STRATEGY & DIGITAL

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,474.958

F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award.

Read SEC document
February 28, 2020 Filed Mar 3, 2020 22:41 UTC
Lotvin AlanEVP, Transformation
GrantStock Unit 11,828 $59.18 $699,981.04
Disclosure

SEC source: 0001127602-20-009164 · form4.xml · nonDerivative · entry 2

Lotvin Alan · CIK 0001472795 · EVP, Transformation

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,945.094

F2 · shares: Consists of Stock Units Awarded at market price pursuant to Issuer's 2017 Incentive Compensation Plan and its Long-Term Incentive Plan, the receipt of which the reporting person has elected to defer.

Read SEC document
February 28, 2020 Filed Mar 3, 2020 22:41 UTC
Lotvin AlanEVP, Transformation
Tax withholdingCommon Stock 160 $59.18 $9,468.80
Disclosure

SEC source: 0001127602-20-009164 · form4.xml · nonDerivative · entry 1

Lotvin Alan · CIK 0001472795 · EVP, Transformation

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,303.3273

F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award.

Read SEC document
February 28, 2020 Filed Mar 3, 2020 22:43 UTC
MERLO LARRY JDirector · President and CEO
Tax withholdingCommon Stock 51,714 $59.18 $3,060,434.52
Disclosure

SEC source: 0001127602-20-009165 · form4.xml · nonDerivative · entry 2

MERLO LARRY J · CIK 0001194413 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 499,364.9407

F2 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of stock awards under the Issuer's 2017 Incentive Compensation Plan and its Long-Term Incentive Plan.

Read SEC document
February 28, 2020 Filed Mar 3, 2020 22:43 UTC
MERLO LARRY JDirector · President and CEO
GrantCommon Stock 114,058 $59.18 $6,749,952.44
Disclosure

SEC source: 0001127602-20-009165 · form4.xml · nonDerivative · entry 1

MERLO LARRY J · CIK 0001194413 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 551,078.9407

F1 · shares: Consists of stock awarded at market price pursuant to Issuer's 2017 Incentive Compensation Plan and its Long-Term Incentive Plan.

Read SEC document
February 28, 2020 Filed Mar 3, 2020 22:45 UTC
Moriarty Thomas MEVP & General Counsel
Tax withholdingCommon Stock 13,457 $59.18 $796,385.26
Disclosure

SEC source: 0001127602-20-009166 · form4.xml · nonDerivative · entry 2

Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,513.0221

F2 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of stock awards under the Issuer's 2017 Incentive Compensation Plan and its Long-Term Incentive Plan.

Read SEC document
February 28, 2020 Filed Mar 3, 2020 22:45 UTC
Moriarty Thomas MEVP & General Counsel
GrantCommon Stock 31,683 $59.18 $1,874,999.94
Disclosure

SEC source: 0001127602-20-009166 · form4.xml · nonDerivative · entry 1

Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 74,970.0221

F1 · shares: Consists of stock awarded at market price pursuant to Issuer's 2017 Incentive Compensation Plan and its Long-Term Incentive Plan.

Read SEC document
February 28, 2020 Filed Mar 3, 2020 22:47 UTC
Roberts Jonathan CEVP & Chief Operating Officer
GrantStock Unit 63,366 $59.18 $3,749,999.88
Disclosure

SEC source: 0001127602-20-009167 · form4.xml · nonDerivative · entry 1

Roberts Jonathan C · CIK 0001410515 · EVP & Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 295,406.0608

F1 · shares: Consists of Stock Units Awarded at market price pursuant to Issuer's 2017 Incentive Compensation Plan and its Long-Term Incentive Plan, the receipt of which the reporting person has elected to defer.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.